Clinical Trial Update: The National Myelodysplastic Syndromes (MDS) Study

View source ↗

Summary

The NHLBI-sponsored National Myelodysplastic Syndromes study (NCT02775383) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myelodysplastic Syndromes (MDS) | Status: COMPLETED